Related content

Improvement in hereditary hemorrhagic telangiectasia after treatment with the phosphoinositide 3-kinase inhibitor BKM120

By Geisthoff Urban   Nguyen Ha-Long   Hess Dagmar  

Annals of Hematology, Vol. 93, Iss. 4, 2014-04 ,pp. : 703-704

Springer Publishing Company

Access to resources Recommend Favorite

Low dose melphalan is a treatment option in elderly patients with high risk myelodysplastic syndrome or secondary acute myeloblastic leukaemia

By Anargyrou Konstantinos   Vaiopoulos George   Terpos Evangelos   Tsironi Maria   Konstantopoulos Konstantinos   Samarkos Michael   Meletis John  

Haematologia, Vol. 32, Iss. 2, 2002-06 ,pp. : 169-173

VSP

Access to resources Recommend Favorite

A postal survey of hereditary hemorrhagic telangectasia in the northeast of England

By Ramakrishnan Yujay   Iqbal Isma Z.   Puvanendran Mark   ElBadawey Mohamed Reda   Carrie Sean  

Allergy & Rhinology, Vol. 6, Iss. 1, 2015-01 ,pp. : e20-e27

OceanSide Publications, Inc

Access to resources Recommend Favorite

Influence of warfarin dose-associated genotypes on the risk of hemorrhagic complications in Chinese patients on warfarin

By Ma Cong  

International Journal of Hematology, Vol. 96, Iss. 6, 2012-12 ,pp. : 719-728

Springer Publishing Company

Access to resources Recommend Favorite

Induction treatment with mycophenolate mofetil, cyclosporine, and low-dose steroids with subsequent early withdrawal in renal transplant patients: results of the Spanish group

By Puig i Mar J.M.  

Transplantation Proceedings, Vol. 31, Iss. 6, 1999-09 ,pp. : 2256-2258

Elsevier

Access to resources Recommend Favorite